SG11202109213RA - Process for preparing 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide - Google Patents

Process for preparing 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide

Info

Publication number
SG11202109213RA
SG11202109213RA SG11202109213RA SG11202109213RA SG11202109213RA SG 11202109213R A SG11202109213R A SG 11202109213RA SG 11202109213R A SG11202109213R A SG 11202109213RA SG 11202109213R A SG11202109213R A SG 11202109213RA SG 11202109213R A SG11202109213R A SG 11202109213RA
Authority
SG
Singapore
Prior art keywords
acryloylpiperidin
phenoxyphenyl
nicotinamide
preparing
Prior art date
Application number
SG11202109213RA
Other languages
English (en)
Inventor
Xiangyang Chen
Original Assignee
Beijing Innocare Pharma Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Innocare Pharma Tech Co Ltd filed Critical Beijing Innocare Pharma Tech Co Ltd
Publication of SG11202109213RA publication Critical patent/SG11202109213RA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Health & Medical Sciences (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
SG11202109213RA 2019-02-25 2020-02-24 Process for preparing 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide SG11202109213RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962810305P 2019-02-25 2019-02-25
PCT/CN2020/076387 WO2020173407A1 (en) 2019-02-25 2020-02-24 Process for preparing 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide

Publications (1)

Publication Number Publication Date
SG11202109213RA true SG11202109213RA (en) 2021-09-29

Family

ID=72238782

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202109213RA SG11202109213RA (en) 2019-02-25 2020-02-24 Process for preparing 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide

Country Status (12)

Country Link
US (1) US20210380555A1 (es)
EP (1) EP3931182A4 (es)
JP (1) JP2022521763A (es)
KR (1) KR20210131374A (es)
CN (1) CN113454066B (es)
AU (1) AU2020229919A1 (es)
BR (1) BR112021016787A2 (es)
CA (1) CA3131302A1 (es)
MX (1) MX2021010199A (es)
SG (1) SG11202109213RA (es)
TW (1) TWI830876B (es)
WO (1) WO2020173407A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115894440A (zh) * 2022-10-27 2023-04-04 都创(重庆)医药科技有限公司 奥布替尼化合物的晶型及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2648923A1 (en) * 2006-04-11 2007-10-18 Vertex Pharmaceuticals Incorporated Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
JP6615752B2 (ja) * 2013-09-30 2019-12-04 グアンジョウ・イノケア・ファーマ・テク・カンパニー・リミテッド Btkの置換ニコチンイミド阻害剤およびそれらの調製、ならびにがん、炎症および自己免疫疾患の治療における使用
CN107226805A (zh) * 2016-03-24 2017-10-03 北京天诚医药科技有限公司 芳香族酰胺类衍生物、其制备方法及其在医药上的应用
WO2020093896A1 (en) * 2018-11-06 2020-05-14 Beijing Innocare Pharma Tech Co., Ltd. Amorphous solid dispersion comprising 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide

Also Published As

Publication number Publication date
WO2020173407A1 (en) 2020-09-03
CN113454066B (zh) 2024-02-09
TW202031642A (zh) 2020-09-01
CN113454066A (zh) 2021-09-28
MX2021010199A (es) 2021-09-21
JP2022521763A (ja) 2022-04-12
EP3931182A1 (en) 2022-01-05
KR20210131374A (ko) 2021-11-02
CA3131302A1 (en) 2020-09-03
EP3931182A4 (en) 2023-01-25
US20210380555A1 (en) 2021-12-09
AU2020229919A1 (en) 2021-10-14
BR112021016787A2 (pt) 2021-11-16
TWI830876B (zh) 2024-02-01

Similar Documents

Publication Publication Date Title
GB2541986B (en) Communication paths for robot arms
EP3325443A4 (en) PROCESS FOR PREPARING PRIDOPIDINE
PL3199479T3 (pl) Sposób przenoszenia artykułów
EP3321272A4 (en) Method for preparing l-bpa
PL3313341T3 (pl) Sposoby przenoszenia oddzielnych wyrobów
IL292429B1 (en) An improved process for the preparation of aminopyrimidine derivatives
SG11202112684SA (en) Processes for preparing aminopyrimidine compounds
EP3393972A4 (en) PROCESS FOR THE PREPARATION OF IRON EXCHANGE ZEOLITE COMPOSITION (III)
EP3276042A4 (en) Method for producing plated article
PL3573988T3 (pl) Sposób wytwarzania pochodnych puryny
SG11202109213RA (en) Process for preparing 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide
EP4055009C0 (en) METHOD OF MANUFACTURING DEXMEDETOMIDINE
SG11202103861YA (en) Amorphous solid dispersion comprising 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide
IL268380B (en) A process for the preparation of halogen-substituted imidazopyridine derivatives
EP3243525A4 (en) Method for treating anemia using long-acting epo preparation
PL3090848T3 (pl) Sposób obróbki płytowych przedmiotów obrabianych
EP3652158A4 (en) METHOD FOR PRODUCING A PYRIMIDONE COMPOUND
IL288950A (en) History of pyridine-3-yl
SG11202102116XA (en) Crystalline forms of 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide
IL282036A (en) A process for the preparation of imidazole derivatives
IL282034A (en) A process for the preparation of modified imidazole derivatives
IL263970B (en) A method for the preparation of halogenated pyridine derivatives
ZA201807239B (en) Method for preparing azoxystrobin
IL255256B (en) A method for the preparation of 5-fluoro-h1-pyrazole-4-carbonyl fluorides
EP3398959A4 (en) METHOD OF PREPARING LIXISENNATIDE